Twist Bioscience (TWST)

• Market cap: $1.82B
• 1 day: -5.43%
• 5 days: 0.43%
• 1 month: 0%
• 3 months: 5.2%
• 6 months: -6.66%
• Year to date: -33.48%
• 1 year: -29.07%
• 5 years: -71.93%
• 10 years: 115.29%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Employees: 923